BENITEC BIOPHARMA INC. (BNTC) Total liabilities 2019–2024
BENITEC BIOPHARMA INC. (BNTC) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2024 · since FY2019: $2.6M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.0M | +16.4% |
| FY2023 | $4.3M | +37.9% |
| FY2022 | $3.1M | +125.8% |
| FY2021 | $1.4M | +1.5% |
| FY2020 | $1.3M | -48.9% |
| FY2019 | $2.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice